Relation between premenstrual syndrome and equol-production status

Area of Science:

• Nutritional Science
• Women's Health
• Metabolomics

Background:

• Soy isoflavones are linked to reduced risk of estrogen-related diseases.
• Equol, a soy isoflavone metabolite, is more bioavailable and may offer greater health benefits.
• Individual differences in gut microbiota influence equol production from soy isoflavones.

Purpose of the Study:

• To investigate the association between premenstrual syndrome (PMS) and equol-producing status in Japanese women of reproductive age.
• To determine if equol production influences the risk or presentation of PMS.
• To explore the role of soy isoflavone metabolism in women's reproductive health.

Main Methods:

• A cross-sectional observational study involving 144 Japanese women (aged 20-45).
• Participants included 46 women diagnosed with PMS and 98 healthy controls.
• Equol production status was assessed via urine samples following a soy challenge test.

Main Results:

• The prevalence of equol producers was significantly lower in the PMS patient group (23.9%) compared to the control group (41.8%).
• Univariate analysis identified PMS and younger age as risk factors for being an equol non-producer.
• Multivariate analysis confirmed that being a PMS patient is a significant risk factor for equol non-production (OR 2.342).

Conclusions:

• This study demonstrates a significant association between premenstrual syndrome (PMS) and reduced equol-production status in Japanese women.
• The findings suggest that impaired metabolism of soy isoflavones to equol may be linked to PMS.
• Further research is warranted to elucidate the causal relationship and potential therapeutic implications.